BU BÖLÜM HAKKINDA

ingilizce
Amerika Birleşik Devletleri

TRANSKRİPT 🔗

SON BÖLÜMLERİ ARA

Pharma Sessions için geçmiş bölümleri ara.

BU PODCAST'IN DİĞER BÖLÜMLERİ

 Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related/ However, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity. In this episode of Pharma Sessions, host Jonathan Kaskey is j…
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earne…
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strate…
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable …
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of pol…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan Jonathan Kaskey'e aittir.